CNS Pharmaceuticals(CNSP) - 2023 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 ___________________________ CNS Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) ___________________________ (State or other jurisdiction of Nevada 001-39126 82-2318545 (Commission File Number) (I.R.S. Employer Identification No.) 2100 West Loop South, ...